Literature DB >> 23089242

Pre-death grief in Parkinson's caregivers: a pilot survey-based study.

J H Carter1, K S Lyons, A Lindauer, J Malcom.   

Abstract

OBJECTIVE: To evaluate the evidence for pre-death grief in caregivers (CGs) of persons with Parkinson's disease (PD) and to compare non-motor PD symptoms (cognitive decline, depression, hallucinations) versus motor symptoms (fluctuations of mobility) for associations with CG grief reactions.
BACKGROUND: Prolonged grief in response to loss has been associated with negative outcomes and decreased well-being in caregivers (i.e. spouse or adult child) of relatives with dementia. In Parkinson's disease (PD) the negative impact of providing care has been referred to as caregiver strain. Grief has not been explored in PD caregivers, and understanding grief may offer new insights for future intervention.
METHODS: Volunteer caregivers (n = 74) filled out the Marwit and Meuser Caregiver Grief Inventory (MM-CGI-SF) which measures 3 types (i.e. subscales) of grief: Personal Sacrifice and Burden, Heartfelt Sadness and Longing, Worry and Felt Isolation. This scale also provided a total grief score. Volunteer caregivers also responded to self-reported UPDRS questions about the motor and non-motor symptoms of their PD relative (i.e. spouse or parent). T-tests were used to correlate CG subscales of grief with patient variables. A hierarchical regression analysis was used to determine the predictive contribution of motor and nonmotor symptoms to grief.
RESULTS: Grief based on the total score was found in 17% of CGs. Grief was significantly higher in CG's whose relative had more severe symptoms. The type of grief experienced was similar across all three subscales. Hierarchical regression analysis revealed that nonmotor symptoms explained slightly more of the variance (14-23%) than motor symptoms (11-17%).
CONCLUSIONS: This study revealed that pre-death grief is a significant finding in PD caregivers. The severity of symptoms and the presence of nonmotor symptoms, especially cognitive decline, predict caregivers who are at greatest risk of prolonged grief; however it should be kept in mind that motor symptoms also contribute.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23089242     DOI: 10.1016/j.parkreldis.2012.06.015

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  6 in total

Review 1.  Palliative Care for Movement Disorders.

Authors:  Christina L Vaughan; Benzi M Kluger
Journal:  Curr Treat Options Neurol       Date:  2018-02-21       Impact factor: 3.598

Review 2.  How Wearable Sensors Can Support Parkinson's Disease Diagnosis and Treatment: A Systematic Review.

Authors:  Erika Rovini; Carlo Maremmani; Filippo Cavallo
Journal:  Front Neurosci       Date:  2017-10-06       Impact factor: 4.677

3.  Cognitive impairment in Parkinson's disease: impact on quality of life of carers.

Authors:  R A Lawson; A J Yarnall; F Johnston; G W Duncan; T K Khoo; D Collerton; J P Taylor; D J Burn
Journal:  Int J Geriatr Psychiatry       Date:  2016-12-07       Impact factor: 3.485

4.  Palliative care for patients with Parkinson's disease: study protocol for a mixed methods study.

Authors:  Herma Lennaerts; Marieke Groot; Maxime Steppe; Jenny T van der Steen; Marieke Van den Brand; Dorian van Amelsvoort; Kris Vissers; Marten Munneke; Bastiaan R Bloem
Journal:  BMC Palliat Care       Date:  2017-11-25       Impact factor: 3.234

5.  Coping with Cognitive Impairment in People with Parkinson's Disease and Their Carers: A Qualitative Study.

Authors:  Rachael A Lawson; Daniel Collerton; John-Paul Taylor; David J Burn; Katie R Brittain
Journal:  Parkinsons Dis       Date:  2018-04-08

6.  "How Long Can I Carry On?" The Need for Palliative Care in Parkinson's Disease: A Qualitative Study from the Perspective of Bereaved Family Caregivers.

Authors:  Herma Lennaerts-Kats; Anne Ebenau; Maxime Steppe; Jenny T van der Steen; Marjan J Meinders; Kris Vissers; Marten Munneke; Marieke Groot; Bastiaan R Bloem
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.